Telix pulls $300m Nasdaq IPO as investors demand deep discount
MELBOURNE: Cancer treatment hopeful Telix Pharmaceuticals has abruptly pulled plans to raise $US200 ...
To read the full story...SUBSCRIBE NOWExisting Subscribers Login Below:
Log In
